A case report of transthyretin amyloidosis following cardiac transplantation: thick ventricles that look alike

• Published in: European heart journal : case reports Vol. 8; no. 8; p. ytae242
• Main Authors: Lauwers, Charlotte, Rosseel, Thomas, Droogné, Walter, Van Aelst, Lucas N L, Van Cleemput, Johan
• Format: Journal Article
• Language: English
• Published: UK Oxford University Press 01-08-2024
• Subjects: Amyloidosis; Case Report; Deafness; Heart; Heart enlargement; Heart failure; Transplantation; Belgium; Heart failure; Biomarkers; Case report; Cardiac transplantation; Amyloidosis; Cardiac imaging
• ISSN: 2514-2119; 2514-2119
• DOI: 10.1093/ehjcr/ytae242

Abstract
Background
Transthyretin (ATTR) amyloidosis is more prevalent than initially thought. As much as 13% of patients hospitalized with heart failure with preserved ejection fraction may have ATTR-cardiomyopathy (CM). Conversely, heart transplant patients may manifest left ventricular hypertrophy or diastolic dysfunction, especially late after transplantation.
Case summary
We present a case of a 82-year-old male heart transplant patient, 31 years following orthotopic heart transplantation. While he was satisfied with his exercise capacity as an octogenarian, several years before, he required pacemaker implantation due to third-degree atrioventricular block, had bilateral carpal tunnel syndrome treated with carpal tunnel release surgery, and experienced idiopathic sudden deafness. Based on increasing left ventricular wall thickness during routine follow-up, a diagnosis of ATTR amyloidosis was suspected. Ultimately, the diagnosis was confirmed non-invasively with a specific scintigraphic exam, while an additional physicochemical stain on an endomyocardial biopsy taken several years before provided pathological proof. We initiated tafamidis, yet stopped this treatment after 1 month because of gastrointestinal intolerance. Ultimately, our patient died 2 years later due to heart failure.
Discussion
Our case shows the long delay between the onset of ATTR deposition, the presence of clinical signs, and the final diagnosis. Echocardiographic findings suggestive for ATTR-CM include left ventricular hypertrophy and diastolic dysfunction, which are both common in heart transplant patients. Yet, ATTR-CM should be considered in the differential diagnosis, especially late after transplantation, in this closely monitored population.